Peptides are short chains of amino acids that act as messengers called growth hormone secretagogues (GHS)
These proteins form a complex of intercellular junctions that act as an intercellular barrier that separates luminal contents from the subepithelial interstitium (Slifer and Blikslager, 2020)
Food and Drug Administration (FDA) as an adjunct to lifestyle changes for weight management in people with obesity or overweight with a related medical complication such as high blood pressure
What Research Says About Weight Loss Results In a 68-week clinical trial of Wegovy, participants lost an average of 15% of their body weight compared to just 2% in the placebo group
While only about 3 percent of Blue Cross members take GLP-1s, about 2,000 members have been joining their ranks each month
Originally developed for diabetes, GLP-1 agonists like semaglutide (Ozempic/Wegovy) and liraglutide have become popular GLP-1s for weight management because they help patients significantly reduce body weight by curbing appetite and calorie intake